Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
affirmative, aglycosylated, amenable, antagonist, antihistamine, aquagenic, atopic, Bayer, began, BeiGene, book, broaden, CFO, chairperson, cholinergic, closure, coordination, Cowen, cyber, dermographism, disaggregated, Eastern, effector, Escient, Evercore, Evommune, excise, FDIC, furniture, helpdesk, IDMC, inaccurate, Indiana, insolvency, insolvent, instability, instruction, Iowa, irritation, itchy, mCitrine, Montana, moving, online, Oregon, overseeing, phone, placebo, platelet, proportionately, proprietor, provocation, punch, receivership, reclassification, refund, revolving, Signature, Silicon, Silvergate, sovereign, steady, stimuli, subcutaneously, subset, sunlight, superseded, swept, symptomatic, taxation, Tennessee, thirty, transfusion, troubled, undrawn, uninsured, Valley, wage, wholly
Removed:
addressing, administering, assembled, Assembly, Bio, biopharma, career, Center, chairman, compound, concurrently, count, developer, diversity, Dr, Erbitux, familiar, female, financially, franchise, funded, highest, identification, imclone, intangible, joining, manager, manipulation, network, oncology, operator, placement, pool, positioned, predicted, promissory, ratio, restricting, simply, sourcing, spread, Subscription, temporary, Vice
Filing tables
Filing exhibits
- 10-K Annual report
- 4.3 Description of Securities of Jasper Therapeutics, Inc
- 10.35 Offer Letter, Dated June 7, 2023, by and Between Jasper Therapeutics, Inc. and Edwin Tucker
- 10.36 Offer Letter, Dated September 19, 2023, by and Between Jasper Therapeutics, Inc. and Herb Cross
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 97 Jasper Therapeutics, Inc. Clawback Policy
- Download Excel data file
- View Excel data file
Related press release
JSPR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-271500 and 333-260306) and S-8 (Nos. 333-273941, 333-270361, 333-263773 and 333-263702) of Jasper Therapeutics, Inc. of our report dated March 5, 2024, relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 5, 2024